相关实验视频
Updated: Jan 8, 2026

06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
11.1K
合成和抗糖尿病评价的新四酸衍生物与计算见解的洞察力
Asmaa M Kadry1, Wafaa A Abdellah2, Mounir A A Mohamed3
1Chemistry Department, Faculty of Science, Sohag University, Sohag, 82524, Egypt. asmaa.kadry@science.sohag.edu.eg.
Scientific reports
|December 12, 2025
概括
新的四氨基 (THA) 衍生物显示出显著的抗糖尿病潜力. 在体内研究表明,THA化合物有效降低了糖尿病老鼠的血糖水平,优于Gliclazide,并显示出新的糖尿病治疗方法的前景.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 糖尿病是一种全球性的健康问题,需要新的治疗药物.
- 现有的抗糖尿病药物可能有局限性,需要探索新的化学支架.
- 四氨基 (THA) 衍生物代表了一类具有潜在药理活性的化合物.
研究的目的:
- 设计和合成新的四氨基 (THA) 衍生物.
- 在体外和体外评估这些THA衍生物的抗糖尿病潜力.
- 调查有前途的候选药物的分子机制和药物相似性.
主要方法:
- 多步合成涉及核友芳香替代和曼尼赫凝结.
- 使用NMR,质谱和元素分析进行结构确认.
- 在体外葡萄糖扩散试验中,对DPP-IV,SGLT1和GLUT2进行分子对接,ADMET预测.
- 在活体中对链毒素诱导的糖尿病大鼠进行抗糖尿病功效的评估.
主要成果:
- 32种THA衍生物成功合成和表征.
- 化合物4b在体外表现出较高的抗糖尿病活性,与格利克拉相比.
- 分子对接揭示了4a,5a和4c化合物潜在的双/三重抑制活性.
- 在体内研究表明,5b,7a和8b化合物显著降低血糖,其中5b是最有效的.
- 被选中的候选人表现出有利的ADMET配置文件和药物相似性.
结论:
- 甲基酸衍生物作为抗糖尿病药物显著有前途.
- 这些化合物表现出多目标潜力和有利的药理动力学特性.
- 需要进一步的研究来开发这些THA衍生物成为临床相关的抗糖尿病药物.
相关概念视频
Oral Hypoglycemic Agents: Sulfonylureas
724
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
724
Oral Hypoglycemic Agents: Glinides
565
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
565
Oral Hypoglycemic Agents: Biguanides and Glitazones
562
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
562
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
505
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
505
Dipeptidyl Peptidase 4 Inhibitors
557
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
557
Insulin: Biosynthesis, Chemistry, and Preparation
1.2K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.2K

